Introduction
Osteoarthritis is a chronic progressive joint disorder characterised by articular cartilage degeneration. It is characterized by pain commonly over the medial joint line and associated with varus and valgus deformity. Physical examination usually is marked by joint line tenderness, crepitus and painful range of movements. The pathological feature are characterized by progressive cartilage destruction, osteophytes formation, capsular fibrosis and subchondral cyst formation with sclerosis of the surrounding bone. Several pharmaceutical approaches, such as analgesics, non steroidal anti -inflammatory drugs, COX -2 inhibitors and steroids (Hochberg et al., 1995) , have been proposed, with the aim of reducing pain and maintaining and / or improving joint function. Corticosteroids are usually administered by intra -articular injection in patients who fail to respond to other conservative measures; in particular, patients with joint effusions and local tenderness may have greater benefit from this option (Flanagan et al., 1988) . Although it has been established that corticosteroid injections are relatively safe, there are concerns regarding their possible adverse effects, following repeated injections. In our study Corticosteroid injection is effective in osteoarthritis (grade I, II ) for short term relief. The extent of pain relief and improvement in KSS is much better in early stages(grade I and II) of OA compared to late stages(grade III)
Aim Of The Study:
To Evaluate The Efficacy Of Intraarticular Steroid Injection In Osteoarthritis Knee
II.
Materials And Methods  The study was carried out on patients with primary osteoarthritis.  This is a prospective study.  Study period was from August 2014 to November 2016.  A total of 50 patients were included in the study. 
4.4: VISUAL ANALOG SCORE (VAS):
The Corticosteroid injection group at the initial visit had VAS of 6.62 respectively. In our study, there was a significant difference in VAS at first and third months compared to sixth month follow-up.
Table showing mean VAS scores and SD at various follow up intervals following corticosteroid injection

4.5: Knee Society Score (Kss):
The Corticosteroid injection group at the initial visit had KSS of 140.58 respectively. KSS increased in the first and third months follow-up followed by a decline in the scores at the end of six months follow-up. 
V. Discussion
In recent years, numerous studies evaluated the efficacy of Corticosteroid injection. Several studies demonstrated that intra articular steroid injection can sufficiently reduce pain, improve function and quality of life.It has been suggested that variation in the response to intra articular steroid therapy may be attributable to inaccurate injection. In a study, Jones et al addressed the issue by obtaining a single plain joint radiograph after joint aspiration and injection in patients who received CS mixed with a radiographic contrast medium. The study addressed accuracy of injection in a series of joints including 59 knees from 109 patients with a spectrum of rheumatological conditions.Accurate injection was associated with successful aspiration of the synovial fluid at the time of injection. Reduction in joint inflammation was in turn, associated with accurate injection. In our study we have aspirated synovial fluid before the injection.In our study patients at good amount of pain relief at initial months compared to the end of six months follow up.
A.Skwara et al in his randomized control study on gait patterns following intra articular Corticosteroid injection stated that single injection shows good range of motion and pain relief as well as improvement in clinical results. In this study most of the patients had full range of motion with terminal pain. Significant gait changes were not noted before the injection in most of the patients.
Seth S Leopold et al in his study on 100 patients has used VAS, knee society score and WOMAC score to evaluate the efficacy of CS intra articular injections in OA knee. Aspiration was done to all patients in both the groups prior to the injection. In his study patients were allowed to have a second injection of CS in their 6 months follow up period. Patients were allowed to take NSAIDs. He has concluded good results with respect to pain relief or function at six months of follow up. In our study we have used VAS and knee society score for evaluation of CS intra articular injection in OA knee. We have done aspiration to all patients prior to the intra articular injection. Only one intra articular injection of CS was given to the patients in 6 months follow up 
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